Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Fouse Jacqualyn A, Chairman & CEO. Insider active across 5 companies, notably INCYTE CORP. Cumulatively, 31 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €176k. History available since 26 May 2021. The latest transaction was disclosed on 20 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Fouse Jacqualyn A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
FOUSE JACQUALYN A is Président-Directeur Général. She has 31 filings in total. Across the 31 sampled recent filings, the recorded amounts show EUR 0 of buys and EUR 176145 of sells, with a date range from 2016-02-16 to 2026-06-23. The filings concern INCYTE CORP, AGIOS PHARMACEUTICALS, INC., Agios Pharmaceuticals, INC., Madrigal Pharmaceuticals, INC. and CELGENE CORP /DE/, and the modal transaction nature is Attribution.